Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials have?
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials has 860 citations in the OpenAlex counts ScholarIQ stores.
When was Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials published?
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials has 2019 year in the ScholarIQ index.
What is the open-access status of Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials?
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials has bronze oa status in the ScholarIQ index.
What is the DOI of Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials?
The DOI for Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials is on the source record.
What is the PMID of Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials?
The PMID for Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials is on the source record.
What is the OpenAlex record for Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials?
The OpenAlex for Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials is on the source record.